VCEL

#1768
Vericel Corporation - Common Stock
33.3 3 USD
-2.66%
Сектор: Здравоохранение
Базовая: USD
Валюта прибыли: USD
Дневной диапазон
33.33
33.33
Годовой диапазон
0.34
43.00
Дневное изменение
-2.66%
Месячное изменение
-0.30%
6-месячное изменение
-16.21%
Годовое изменение
-8.31%
Предыдущее закрытие
34.2 4
Open
33.3 3
Low
33.3 3
High
33.3 3
Volume
114
Открыть полный график Full chart

Financials

Обзор Отчетность Статистика
Квартал Год
  • Market Capitalization 1.7 B
  • Employee 398
  • Founded 1989
  • CEO Nick Colangelo
  • Website www.vcel.com
  • Headquarter Michigan, United States
  • FIGI BBG000BDCM24
  • Industry Биотехнологии
Общий доход
Чистая прибыль
Базовая прибыль на акцию
Общий долг
Свободный денежный поток
Денежные средства и эквиваленты
Коэффициент цена/прибыль
112.53
Коэффициент цена/денежный поток
6.8

Vericel Corporation - Common Stock

Vericel Corporation is a publicly traded American biopharmaceutical company which was known prior to October 2014 as Aastrom Bio. Aastrom Bio was formed in 1989 in Ann Arbor, Michigan. In the spring of 2014, Aastrom Bio acquired Sanofi's cell therapy and regenerative medicine business which Sanofi had acquired when purchasing Genzyme in 2011. This transformed Aastrom in several ways: it increased the employee count by 8-fold and provided a revenue stream and products to market, which it had not had before. In October 2014, the company changed its name from Aastrom Bio to Vericel and relocated its headquarters from Ann Arbor, Michigan to Cambridge, Massachusetts.

Новости